Search by Drug Name or NDC

    NDC 42291-0429-10 Glipizide 5 mg/1 Details

    Glipizide 5 mg/1

    Glipizide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is GLIPIZIDE.

    Product Information

    NDC 42291-0429
    Product ID 42291-429_d57cc326-d855-0598-e053-2995a90acd95
    Associated GPIs 27200030000305
    GCN Sequence Number 001777
    GCN Sequence Number Description glipizide TABLET 5 MG ORAL
    HIC3 C4K
    HIC3 Description ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE
    GCN 10840
    HICL Sequence Number 000803
    HICL Sequence Number Description GLIPIZIDE
    Brand/Generic Generic
    Proprietary Name Glipizide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Glipizide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name GLIPIZIDE
    Labeler Name AvKARE
    Pharmaceutical Class Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075795
    Listing Certified Through 2023-12-31

    Package

    NDC 42291-0429-10 (42291042910)

    NDC Package Code 42291-429-10
    Billing NDC 42291042910
    Package 1000 TABLET in 1 BOTTLE (42291-429-10)
    Marketing Start Date 2019-06-25
    NDC Exclude Flag N
    Pricing Information N/A